Bristol-Myers Squibb

Bristol-Myers Squibb Named to Top Corporate Citizen List for Ninth Consecutive Year

Article

For the ninth consecutive year, Bristol-Myers Squibb ranks in the top 20 of the 100 Best Corporate Citizens, a leading benchmark for socially responsible investors and other stakeholders published by Corporate Responsibility magazine. 

Bristol-Myers Squibb Celebrates Earth Day [Video]

Multimedia with summary

Happy Earth Day! To celebrate, we're featuring our new, state-of-the art office facility that constructed with collaboration and the environment in mind.

Bristol-Myers Squibb Contributes to a Healthy Environment

Multimedia with summary

Contributing to a healthy environment requires a strong willingness to give back. See how we’re making an impact: #EarthDay

Cancer in the Community: Understanding and Addressing Cultural Forces

By Chris Boerner, President and Head of U.S. Commercial
Blog

Over the past four decades, we have seen an unprecedented increase in cancer care innovation.

While only half of diagnosed cancer patients survived beyond five years in the 1970s, more than two-thirds do today. As a result, there are now a record 14 million cancer survivors in the United States. 

First Comprehensive Pediatric Hematology-Oncology Initiative Launched in Africa

Summary: 
  • Government of Botswana announces new public-private partnership to treat children with cancer and blood disorders
  • The $100 million initiative to create a pediatric hematology-oncology treatment network and care infrastructure is supported by $50 million donation from the Bristol-Myers Squibb Foundation and matched by $50 million in additional philanthropy 
  • Partnership includes Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital and the Governments of Botswana, Uganda and Malawi
Press Release
  • Government of Botswana announces new public-private partnership to treat children with cancer and blood disorders
  • The $100 million initiative to create a pediatric hematology-oncology treatment network and care infrastructure is supported by $50 million donation from the Bristol-Myers Squibb Foundation and matched by $50 million in additional philanthropy 
  • Partnership includes Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital and the Governments of Botswana, Uganda and Malawi

First Comprehensive Pediatric Hematology-Oncology Initiative Launched in Africa

Summary: 
  • Government of Botswana announces new public-private partnership to treat children with cancer and blood disorders
  • The $100 million initiative to create a pediatric hematology-oncology treatment network and care infrastructure is supported by $50 million donation from the Bristol-Myers Squibb Foundation and matched by $50 million in additional philanthropy 
  • Partnership includes Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital and the Governments of Botswana, Uganda and Malawi
Press Release
  • Government of Botswana announces new public-private partnership to treat children with cancer and blood disorders
  • The $100 million initiative to create a pediatric hematology-oncology treatment network and care infrastructure is supported by $50 million donation from the Bristol-Myers Squibb Foundation and matched by $50 million in additional philanthropy 
  • Partnership includes Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital and the Governments of Botswana, Uganda and Malawi

Bristol-Myers Squibb’s Coast 2 Coast 4 Cancer Ride Raises Over $1 Million for Cancer Research

For third year in a row, BMS employees participated in a cycling relay to raise funds for Stand Up To Cancer’s efforts to accelerate cancer research
Press Release

PRINCETON, N.J., October 28, 2016 /3BL Media/ --Bristol-Myers Squibb’s (NYSE:BMY) 

Bristol-Myers Squibb Foundation Joins White House Cancer Moonshot

$25MM in funding will expand scope of community-based cancer treatment, care and support for underserved patients
Press Release

NEW YORK, October 17, 2016 /3BL Media/ -- Today the Bristol-Myers Squibb Foundation joins the White House Cancer Moonshot initiative through its commitment to addressing health disparities in cancer care. In response to the Cancer Moonshot, the Foundation is committing $25 million in new funding to grantee partners to expand the current scope of community-based resources and survivorship support programs to underserved populations in the U.S.

Bristol-Myers Squibb Supports Haitian Hurricane Relief Efforts

Press Release

NEW YORK, October 10, 2016 /3BL Media/ -- Bristol-Myers Squibb and the Bristol-Myers Squibb Foundation are supporting emergency relief effort in Haiti following the Category 4 hurricane which hit the island on October 4, destroying homes and crops, flooding streets and cutting off transportation across the island. Haiti is the poorest country in the Western Hemisphere and has been plagued by natural disasters over the past decade.

The company is donating $600,000 in medicines to help the people of Haiti.

Pages

Subscribe to Bristol-Myers Squibb